GlaxoSmithKline Biologicals SA;The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services
发明人:
申请号：
EP11769662.5
公开号：
EP2560680B1
申请日:
2011.04.15
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
This invention provides vaccines for inducing an immune response and protection against filovirus infection for use as a preventative vaccine in humans. In particular, the invention provides chimpanzee adenoviral vectors expressing filovirus proteins from different strains of Ebolavirus (EBOV) or Marburg virus (MARV).
